Cost-Effectiveness Analysis Of Interventions That Have Not Shown Clinical Effectiveness

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cost-Effectiveness Analysis of Health Interventions: A Critical Review

Background and Aim: Economic evaluation of health interventions by comparing the relevant costs and benefits will result in optimum allocation of resources and increasing the effectiveness of the health system and, through improving equity and increasing accessibility to health services, will lead to increased effectiveness of the health system. The purpose of this study was to critically evalu...

متن کامل

Cost effectiveness analysis of smoking cessation interventions.

OBJECTIVE To identify which smoking cessation interventions provide the most efficient use of health care resources at a population level. METHODS Effectiveness data were obtained from a review of the international literature. Costs and effects of smoking cessation interventions were estimated from the perspective of the Australian Government. Treatment costs and effects were modelled using i...

متن کامل

Cost-effectiveness of coronary interventions.

As the costs of medical care continue to rise, there has been increasing interest in evaluating the cost-effectiveness of medical practices. One area that has received particular scrutiny in recent years is percutaneous coronary revascularisation (PTCA). In the United States alone, more than 300 000 PTCAs are performed each year at an estimated cost of approximately US$3 billion. Despite the tr...

متن کامل

The primacy of clinical effectiveness for cost effectiveness analysis.

Despite the many advances in cardiovascular therapeutics over the last two decades, the incidence of death or myocardial infarction in the six months following clinical presentation with acute coronary syndromes (ACS) (excluding ST elevation myocardial infarction) remains unacceptably high at 12–15% (fig 1). Most ACS trials have focused on reducing ischaemic events during the in-hospital treatm...

متن کامل

Cost-effectiveness analysis and clinical practice.

H eart failure is the leading cause of hospitalization in adults older than 65 years, and it is currently the most costly cardiovascular disorder in the United States, with estimated annual expenditures in excess of $20 billion. Recent studies have shown that selected pharmacological agents, behavioral interventions, and surgical therapies are associated with improved clinical outcomes in patie...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2017

ISSN: 1098-3015

DOI: 10.1016/j.jval.2017.08.2102